(Total Views: 728)
Posted On: 06/29/2020 6:57:18 AM
Post# of 153903
“Not the PR I was hoping for, but atleast we got something.”
Not sure what PR you were hoping for. Data is not expected for at least another week or two, maybe a look at mortality earlier if it’s clear. Uplisting? That a possibility.
Honestly, the Mexico news is great news. This is another avenue for approval and could further demonstrate leronlimab’s efficacy. If the trial goes well and Mexico approved the drug, it will be international news and other countries may follow, especially if data from the M2M and severe trial is available at that time.
Not sure what PR you were hoping for. Data is not expected for at least another week or two, maybe a look at mortality earlier if it’s clear. Uplisting? That a possibility.
Honestly, the Mexico news is great news. This is another avenue for approval and could further demonstrate leronlimab’s efficacy. If the trial goes well and Mexico approved the drug, it will be international news and other countries may follow, especially if data from the M2M and severe trial is available at that time.
(2)
(0)
